Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
16.5M
-
Shares change
-
+229K
-
Total reported value, excl. options
-
$224M
-
Value change
-
+$1.37M
-
Number of buys
-
38
-
Number of sells
-
-17
-
Price
-
$13.54
Significant Holders of Kiniksa Pharmaceuticals Intern - COM (KNSA) as of Q2 2019
63 filings reported holding KNSA - Kiniksa Pharmaceuticals Intern - COM as of Q2 2019.
Kiniksa Pharmaceuticals Intern - COM (KNSA) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.5M shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (2.8M shares), HILLHOUSE CAPITAL ADVISORS, LTD. (1.84M shares), ArrowMark Colorado Holdings LLC (1.78M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.31M shares), VANGUARD GROUP INC (1.24M shares), BlackRock Inc. (1.11M shares), Sofinnova Investments, Inc. (923K shares), Vivo Capital, LLC (843K shares), AMERIPRISE FINANCIAL INC (746K shares), and FMR LLC (635K shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.